Product
MSB0254
1 clinical trial
1 indication
Indication
Advanced Solid TumorClinical trial
Phase I Clinical Trial to Evaluate the Safety and Tolerability and Pharmacokinetics of MSB0254 Injection in Patients With Advanced Solid TumorsStatus: Terminated, Estimated PCD: 2022-06-08